N I Nissen

RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE

J Pedersen-Bjergaard, Severin Olesen Larsen, J. Struck et al. · The Lancet · 1987 · 223 citations

Medicine, Oncology, Cancer Epidemiology +8

Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.

Glicksman As, Pajak Tf, A. Gottlieb et al. · PubMed · 1982 · 148 citations

Veterinary Medicine, Oncology, Neoplasia +9

Effect of age on therapeutic response and survival in advanced Hodgkin's disease.

B. A. Peterson, Thomas F. Pajak, M. R. Cooper et al. · PubMed · 1982 · 73 citations

Medicine, Oncology, Pharmacology +11

Chemotherapy and combined modality therapy for Hodgkin's disease: a progress report on Cancer and Leukemia Group B studies.

C. D. Bloomfield, T F Pajak, Arvin S. Glicksman et al. · PubMed · 1982 · 51 citations

Medicine, Oncology, Radiation Oncology +16

Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B.

V. Vinciguerra, Kathleen J. Propert, Morton Coleman et al. · Journal of Clinical Oncology · 1986 · 38 citations

Medicine, Oncology, Radiation Oncology +16